# Ventria Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ventria-biosciences

- Industry: Biotechnology
- Headquarters: Fort Collins, US
- Website: www.ventriabio.com
- Total disclosed funding: $6M
- Latest round: Series J (Nov 15, 2006)
- Investors on record: 1

## About

Ventria Biosciences, Inc. specializes in producing recombinant proteins using a novel plant-based system that harnesses rice plants, facilitating efficient protein synthesis for medical and biotechnology applications.Founded in 1993, Ventria Biosciences, Inc. operates out of Fort Collins, US, focusing on recombinant proteins. The company raised USD 6.00 mn in its most recent Series J funding round on November 15, 2006, from Vista Ventures, contributing to its total amount raised of USD 6.00 mn. Scott Deeter leads the company as CEO.Ventria's ExpressTec division specializes in producing recombinant proteins through a unique plant-based method utilizing rice plants. This technology enables the concentration of proteins in the rice-seed endosperm, simplifying the harvesting and purification process. The company's products cater primarily to the pharmaceutical and biotechnology sectors, addressing the need for high-quality proteins in drug development and diagnostics, with a market focus on North America and Europe.Ventria's revenue model is based on direct business-to-business sales within healthcare and biotechnology. Clients order specific recombinant proteins, engaging in volume-based pricing agreements for competitive rates. The company also offers trademarked flagship products, with pricing aligned to purity and application. Collaborations with pharmaceutical companies and research institutions are key to generating a consistent order flow.Ventria aims to enhance its product line with new recombinant proteins under development, planning for market launches in the coming years. The company seeks to expand its reach into additional markets in Europe and Asia by 2025. The recent funding of USD 6.00 mn will support these initiatives, aiding in product development and market expansion efforts.

## Funding rounds

- Series J, Nov 15, 2006, $6M — Vista Ventures

## Investors

- Vista Ventures (https://capitalatlas.ai/funds/vista-ventures) — Series J
